Atlas Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$74.2K Buy
3,062
+400
+15% +$9.7K 0.01% 574
2025
Q1
$67.5K Buy
2,662
+1,000
+60% +$25.3K 0.01% 597
2024
Q4
$44.1K Sell
1,662
-1,240
-43% -$32.9K 0.01% 629
2024
Q3
$84K Buy
2,902
+1,800
+163% +$52.1K 0.01% 517
2024
Q2
$30.8K Sell
1,102
-600
-35% -$16.8K ﹤0.01% 646
2024
Q1
$47.2K Buy
1,702
+600
+54% +$16.7K 0.01% 577
2023
Q4
$31.7K Sell
1,102
-3,076
-74% -$88.6K ﹤0.01% 642
2023
Q3
$139K Sell
4,178
-803
-16% -$26.6K 0.02% 397
2023
Q2
$183K Sell
4,981
-1,384
-22% -$50.8K 0.03% 383
2023
Q1
$260K Sell
6,365
-22,507
-78% -$918K 0.04% 307
2022
Q4
$1.48M Sell
28,872
-1,369
-5% -$70.1K 0.25% 79
2022
Q3
$1.32M Sell
30,241
-155
-0.5% -$6.78K 0.24% 80
2022
Q2
$1.59M Sell
30,396
-2,360
-7% -$124K 0.27% 75
2022
Q1
$1.7M Buy
32,756
+389
+1% +$20.1K 0.26% 85
2021
Q4
$1.91M Buy
32,367
+4,321
+15% +$255K 0.28% 77
2021
Q3
$1.21M Buy
28,046
+19,828
+241% +$853K 0.19% 99
2021
Q2
$322K Buy
8,218
+25
+0.3% +$979 0.05% 280
2021
Q1
$297K Sell
8,193
-1,796
-18% -$65.1K 0.06% 272
2020
Q4
$368K Sell
9,989
-4,714
-32% -$174K 0.08% 221
2020
Q3
$512K Sell
14,703
-1,223
-8% -$42.6K 0.12% 179
2020
Q2
$494K Buy
15,926
+14,570
+1,074% +$452K 0.12% 182
2020
Q1
$42K Buy
1,356
+237
+21% +$7.34K 0.01% 458
2019
Q4
$41.6K Hold
1,119
0.01% 484
2019
Q3
$38.2K Sell
1,119
-11,382
-91% -$388K 0.01% 480
2019
Q2
$514K Sell
12,501
-19,036
-60% -$782K 0.17% 165
2019
Q1
$1.27M Sell
31,537
-3,330
-10% -$134K 0.46% 62
2018
Q4
$1.44M Buy
34,867
+33,762
+3,055% +$1.4M 0.58% 42
2018
Q3
$47K Hold
1,105
0.02% 425
2018
Q2
$39.5K Sell
1,105
-11,948
-92% -$427K 0.01% 415
2018
Q1
$440K Buy
+13,053
New +$440K 0.13% 200